Healthcare-associated pneumonia: a US disease or relevant to the Asia Pacific, too? (Q38109968)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23714303%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

title

Healthcare-associated pneumonia: a US disease or relevant to the Asia Pacific, too? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23714303%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

0 references

1 August 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23714303%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23714303%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23714303%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23714303%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

page(s)

923-932

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23714303%20AND%20SRC:MED&resulttype=core&format=json

Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia

2 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12132

The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12132

Population-based incidence and characteristics of community-onset Staphylococcus aureus infections with bacteremia in 4 metropolitan Connecticut areas, 1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12132

Community-acquired methicillin-resistant Staphylococcus aureus infection in Singapore is usually "healthcare associated".

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12132

Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12132

Impact of invasive strategy on management of antimicrobial treatment failure in institutionalized older people with severe pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12132

A hospital study of community acquired pneumonia in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12132

Community-acquired pneumonia in the elderly: A multivariate analysis of risk and prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12132

Community-acquired pneumonia in the elderly: Spanish multicentre study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12132

Guidelines for the management of adult lower respiratory tract infections--full version

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12132

Community-acquired pneumonia guidelines: a global perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12132

Healthcare-associated pneumonia in adults: management principles to improve outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12132

Healthcare-associated pneumonia: principles and emerging concepts on management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12132

Health care-associated pneumonia: identification and initial management in the ED.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12132

Health care-associated pneumonia (HCAP): a critical appraisal to improve identification, management, and outcomes--proceedings of the HCAP Summit

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12132

Epidemiology of healthcare-associated pneumonia (HCAP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12132

What are the important risk factors for healthcare-associated pneumonia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12132

Diagnostic strategies for healthcare-associated pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12132

Healthcare-associated pneumonia in the emergency department

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12132

The role of MRSA in healthcare-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12132

The role of gram-negative bacteria in healthcare-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12132

Healthcare-associated atypical pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12132

Prevention strategies for healthcare-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12132

New antibiotics for healthcare-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12132

Current perspective of the HCAP problem: is it CAP or is it HAP?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12132

Rethinking the concepts of community-acquired and health-care-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12132

Healthcare-associated pneumonia is a heterogeneous disease, and all patients do not need the same broad-spectrum antibiotic therapy as complex nosocomial pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12132

Health care-associated pneumonia: an evidence-based review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12132

Is healthcare-associated pneumonia a distinct entity needing specific therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12132

Health care-associated pneumonia and community-acquired pneumonia: a single-center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12132

Low incidence of multidrug-resistant organisms in patients with healthcare-associated pneumonia requiring hospitalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12132

Clinical characteristics of health care-associated pneumonia in a Korean teaching hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12132

Healthcare-associated pneumonia among hospitalized patients in a Korean tertiary hospital.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12132

Outcomes of patients hospitalized with community-acquired, health care-associated, and hospital-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12132

Why mortality is increased in health-care-associated pneumonia: lessons from pneumococcal bacteremic pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12132

community-acquired infection with healthcare-associated methicillin-resistant Staphylococcus aureus: the role of home nursing care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12132

A prospective comparison of nursing home-acquired pneumonia with hospital-acquired pneumonia in non-intubated elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12132

Indicators of potentially drug-resistant bacteria in severe nursing home-acquired pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12132

Factors influencing in-hospital mortality in community-acquired pneumonia: a prospective study of patients not initially admitted to the ICU.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12132

Resistant pathogens in nonnosocomial pneumonia and respiratory failure: is it time to refine the definition of health-care-associated pneumonia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12132

Guideline-concordant therapy and outcomes in healthcare-associated pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12132

Implementation of guidelines for management of possible multidrug-resistant pneumonia in intensive care: an observational, multicentre cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12132

Effect of a clinical pathway to reduce hospitalizations in nursing home residents with pneumonia: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12132

Once-daily cefepime versus ceftriaxone for nursing home-acquired pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12132

Ertapenem versus cefepime for initial empirical treatment of pneumonia acquired in skilled-care facilities or in hospitals outside the intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12132

Impact of aspiration pneumonia in patients with community-acquired pneumonia and healthcare-associated pneumonia: a multicenter retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12132

The difference in clinical presentations between healthcare-associated and community-acquired pneumonia in university-affiliated hospital in Korea

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12132

Comparison of clinical characteristics between healthcare-associated pneumonia and community-acquired pneumonia in patients admitted to secondary hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12132

Antimicrobial drug-resistant microbes associated with hospitalized community-acquired and healthcare-associated pneumonia: a multi-center study in Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12132

Toxicity and response criteria of the Eastern Cooperative Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12132

A prospective comparison of nursing- and healthcare-associated pneumonia (NHCAP) with community-acquired pneumonia (CAP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12132

The definition of healthcare-associated pneumonia (HCAP) is insufficient for the medical environment in Japan: a comparison of HCAP and nursing and healthcare-associated pneumonia (NHCAP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12132

Clinical features and the role of atypical pathogens in nursing and healthcare-associated pneumonia (NHCAP): differences between a teaching university hospital and a community hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12132